Frontiers in Neurology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 27, 2024
Traumatic
brain
injury
(TBI)
is
common
and
costly.
Although
neuroimaging
modalities
such
as
resting-state
functional
MRI
(rsfMRI)
promise
to
differentiate
injured
from
healthy
brains
prognosticate
long-term
outcomes,
the
field
suffers
heterogeneous
findings.
To
assess
whether
this
heterogeneity
stems
variability
in
TBI
populations
studied
or
imaging
methods
used,
determine
a
consensus
exists
literature,
we
performed
first
systematic
review
of
studies
comparing
rsfMRI
connectivity
(FC)
patients
with
matched
controls
for
seven
canonical
networks
across
severity,
age,
chronicity,
population
type,
various
methods.
Searching
PubMed,
Web
Science,
Google
Scholar,
ScienceDirect,
1,105
manuscripts
were
identified,
50
fulfilling
our
criteria.
Across
these
manuscripts,
179
comparisons
reported
between
total
1,397
1,179
controls.
Collapsing
characteristics,
methods,
networks,
there
roughly
equal
significant
null
findings
increased
decreased
differences
reported.
Whereas
most
factors
did
not
explain
mixed
findings,
stratifying
severity
separately,
showed
trend
at
higher
severities
greater
chronicities
TBI.
Among
methodological
factors,
more
likely
find
when
scans
longer
than
360
s,
custom
image
processing
pipelines
kept
their
eyes
open
versus
closed
during
scans.
We
offer
guidelines
address
variability,
focusing
on
aspects
study
design
acquisition
move
toward
reproducible
results
potential
clinical
translation.
Neuroscience,
Journal Year:
2024,
Volume and Issue:
551, P. 79 - 93
Published: May 16, 2024
It
is
increasingly
evident
that
blood
biomarkers
have
potential
to
improve
the
diagnosis
and
management
of
both
acute
chronic
neurological
disorders.
The
most
well-studied
candidates,
arguably
those
with
broadest
utility,
are
proteins
highly
enriched
in
neural
tissues
released
into
circulation
upon
cellular
damage.
currently
unknown
how
brain
expression
levels
these
influenced
by
demographic
factors
such
as
sex,
race,
age.
Given
source
tissue
abundance
likely
a
key
determinant
observed
during
pathology,
understanding
influences
important
terms
identifying
clinical
scenarios
could
produce
diagnostic
bias.
In
this
study,
we
leveraged
existing
mRNA
sequencing
data
originating
from
2,642
normal
specimens
harvested
382
human
donors
examine
variability
genes
which
code
for
28
candidate
Existing
mass
spectrometry
26
additional
separate
was
subsequently
used
tentatively
assess
whether
transcriptional
variance
corresponding
protein
abundance.
Genes
associated
several
or
emerging
including
neurofilament
light
chain
(NfL),
ubiquitin
carboxyl-terminal
hydrolase
isozyme
L1
(UCH-L1),
neuron-specific
enolase
(NSE),
synaptosomal-associated
25
(SNAP-25)
exhibited
significant
differences
respect
many
instances,
align
well
provide
mechanistic
explanation
previously
reported
levels.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 6, 2024
AbstractBackground
Head
impacts
are
common
in
contact
sports
such
as
boxing
and
occur
at
times
of
elevated
core
body
brain
temperatures
induced
by
the
exercise.
Following
impact,
temperature
may
lead
to
development
exacerbated
injury
that
can
be
monitored
blood
biomarkers.
We
hypothesized
acute
head-and-neck
cooling,
recently
shown
shorten
return-to-play
concussed
ice
hockey
players,
applied
acutely
following
a
bout
is
associated
with
an
attenuated
release
biomarkers
improved
symptom
rating.
Methods
The
trial
academically
driven
funded
external
hospital
research
funds.
Young,
healthy
elite
boxers
≥
18
years
old
recruited.
Prior
to,
immediately
after
competitive
over
3x2
or
3x3
minutes,
samples
drawn.
Boxers
randomized
intervention
control
management
1:1
allocation
prior
baseline
testing.
After
initial
post-fight
sample
drawn
rating
using
concussion
assessment
tool-5
(SCAT-5)
has
been
collected,
receive
either
selective
cooling
for
45
min,
routine
management.
number
head
counted
all
on
match
video
recordings.
In
both
groups,
minutes
post-bout
sample,
well
3
6
days
post-fight.
At
time
points
sampling,
symptoms
(NOS)
severity
score
(SSS)
assessed
part
SCAT-5.
primary
endpoint
difference
biomarker
levels
(GFAP,
NF-L,
tau,
UCH-L1,
neuronal-specific
enolase)
between
pre-intervention
levels,
those
obtained
SCAT-5
NOS
SSS
secondary
endpoints.
Discussion
There
no
treatment
available
boxing-induced
injury.
Biomarkers
surrogate
yet
objective
marker
injury,
attenuate
injury-related
reduce
attained
during
fight.
Potentially,
option
bout.
Trials
registration
ClinicalTrials.gov,
ClinicalTrials.gov
Identifier
NCT06386484.
Registered
April
23,
2024.
Frontiers in Neurology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 27, 2024
Traumatic
brain
injury
(TBI)
is
common
and
costly.
Although
neuroimaging
modalities
such
as
resting-state
functional
MRI
(rsfMRI)
promise
to
differentiate
injured
from
healthy
brains
prognosticate
long-term
outcomes,
the
field
suffers
heterogeneous
findings.
To
assess
whether
this
heterogeneity
stems
variability
in
TBI
populations
studied
or
imaging
methods
used,
determine
a
consensus
exists
literature,
we
performed
first
systematic
review
of
studies
comparing
rsfMRI
connectivity
(FC)
patients
with
matched
controls
for
seven
canonical
networks
across
severity,
age,
chronicity,
population
type,
various
methods.
Searching
PubMed,
Web
Science,
Google
Scholar,
ScienceDirect,
1,105
manuscripts
were
identified,
50
fulfilling
our
criteria.
Across
these
manuscripts,
179
comparisons
reported
between
total
1,397
1,179
controls.
Collapsing
characteristics,
methods,
networks,
there
roughly
equal
significant
null
findings
increased
decreased
differences
reported.
Whereas
most
factors
did
not
explain
mixed
findings,
stratifying
severity
separately,
showed
trend
at
higher
severities
greater
chronicities
TBI.
Among
methodological
factors,
more
likely
find
when
scans
longer
than
360
s,
custom
image
processing
pipelines
kept
their
eyes
open
versus
closed
during
scans.
We
offer
guidelines
address
variability,
focusing
on
aspects
study
design
acquisition
move
toward
reproducible
results
potential
clinical
translation.